Metabolism of the new ribonucleotide reductase inhibitor amidox in the isolated perfused rat liver

Anticancer Research

Volumn 20, Issue 5 B, 2000, Pages 3521-3526

  Salamon, A ^a   Vielnascher, E ^a   Hagenauer, B ^a   Szekeres, T ^a   Szekeres Fritzer, M ^a   Thalhammer, T ^a   Jager, W ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Amidox; Cmoat; Isolated perfused rat liver; Metabolism; Ribonucleotide reductase inhibitor

Indexed keywords

AMIDOX; RIBONUCLEOTIDE REDUCTASE;

ANIMAL EXPERIMENT; ARTICLE; BILE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG EXCRETION; DRUG METABOLISM; DRUG TRANSFORMATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATED LIVER; LIVER METABOLISM; LIVER PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANION TRANSPORT PROTEINS; ANTINEOPLASTIC AGENTS; BILE; BIOTRANSFORMATION; CARRIER PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; LIVER; MALE; OXIMES; PERFUSION; RATS; RATS, MUTANT STRAINS; RATS, WISTAR; RIBONUCLEOTIDE REDUCTASES;

EID: 0033637482     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Reduction of ribonucleotides
2. Ribonucleotide reductase and cell proliferation
3. Role of ribonucleotide reductase in expression of the neoplastic program
4. Enzymology of cancer cells
5. Inhibition of ribonucleotase diphosphate reductase by hydroxyurea
6. Hydroxyurea as an inhibitor of human immunodeficiency virus type 1 replication
7. Gemcitabine: Metabolism, mechanism of action, and self-potentition
8. Fludarabine inhibits DNA replication: A rationale for its use in the tratment of acute leukemias
9. Inhibition of nucleoside diphosphate reductase by hydroxybenzohydroxamic acid derivates
10. The enzyme ribonucleotide reductase: Target for antitumor and anti-HIV therapy
11. Studies on the mechanism of inhibition of L1210 cell growth by 3,4-dihydroxybenzohydroxamic acid and 3,4-dihydroxybenzamidoxim
12. Amidox, antineoplastic ribonucleotide reductase inhibitor
13. Iron binding capacity of didox (3,4 dihydroxybenzohydroxymic acid) and amidox (3,4 dihydroxybenzamidoxime) two inhibitors of the enzyme ribonucleotide reductase
14. Iron binding capacity of didox (3,4 dihydroxybenzohydroxymic acid) and amidox (3,4 dihydroxybenzamidoxime) new inhibitors of the enzyme ribonucleotide reductase
15. Modulation of liver canalicular processes by the tyrosine-kinase inhibitor genistein: Implications of genistein metabolism in the rat
16. Simultaneous determination of the new anticancer agent amidox and its metabolites in rat bile and plasma by high performance liquid chromatography
17. The disposition of morphine and its metabolites in the in situ rat isolated perfused liver
18. A phase I and pharmacokinetic study of didox: A ribonucleotide reductase inhibitor
19. Defective biliary excretion of epinephrine metabolites in mutant (TR-) rats: Relation to the pathogenesis of black liver in the Dubin-Johnson syndrome and Corriedale sheep with a analogous excretory defect
20. Selective hepatobiliary transport defect for organic anions and neutral steroids in mutant rats with hereditary conjugated hyperbilirubinemia